Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (191-200 of 422) with videos related to

Pageof 43
Sort By:
Bone Marrow Transplantation|September 7, 2021
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Hematological Oncology|March 17, 2022
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysisHidehiro Itonaga, Michiko Kida, Atsushi Hamamura, et al.
Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 12, 2013
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantationKoji Kawamura, Hidenori Wada, Ryoko Yamasaki, et al.
Cytotherapy|May 9, 2022
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsKaito Harada, Mari Morita-Fujita, Takahiro Fukuda, et al.
Blood Advances|June 12, 2019
BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipientHideki Nakasone, Koji Kawamura, Kimikazu Yakushijin, et al.
Bone Marrow Transplantation|October 9, 2021
Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantationShinichi Kobayashi, Yoshinobu Kanda, Takaaki Konuma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood TransplantationJunya Kanda, Takakazu Kawase, Hidenori Tanaka, et al.
International Journal of Hematology|January 13, 2017
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemiaJin Hayakawa, Junya Kanda, Yu Akahoshi, et al.
Bone Marrow Transplantation|April 10, 2025
Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for childrenMotohiro Kato, Hideki Nakashone, Keitaro Matsuo, et al.
Pageof 43

Showing results (191-200 of 422) with videos related to

Sort By:
Pageof 43
Bone Marrow Transplantation|September 7, 2021
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Hematological Oncology|March 17, 2022
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysisHidehiro Itonaga, Michiko Kida, Atsushi Hamamura, et al.
Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 12, 2013
Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantationKoji Kawamura, Hidenori Wada, Ryoko Yamasaki, et al.
Cytotherapy|May 9, 2022
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsKaito Harada, Mari Morita-Fujita, Takahiro Fukuda, et al.
Blood Advances|June 12, 2019
BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipientHideki Nakasone, Koji Kawamura, Kimikazu Yakushijin, et al.
Bone Marrow Transplantation|October 9, 2021
Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantationShinichi Kobayashi, Yoshinobu Kanda, Takaaki Konuma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood TransplantationJunya Kanda, Takakazu Kawase, Hidenori Tanaka, et al.
International Journal of Hematology|January 13, 2017
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemiaJin Hayakawa, Junya Kanda, Yu Akahoshi, et al.
Bone Marrow Transplantation|April 10, 2025
Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for childrenMotohiro Kato, Hideki Nakashone, Keitaro Matsuo, et al.
Pageof 43